APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metabotropic Glutamate Receptor 3

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Metabotropic Glutamate Receptor 3 Industry Growth and Trends Forecast to 2032

19 December 202589 pages

Choose your research edition.

Industry ResearchMetabotropic Glutamate Receptor 3 Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Metabotropic Glutamate Receptor 3 Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Metabotropic Glutamate Receptor 3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metabotropic Glutamate Receptor 3 Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Metabotropic Glutamate Receptor 3 Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

According to APO Research, the global Metabotropic Glutamate Receptor 3 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Metabotropic Glutamate Receptor 3 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Metabotropic Glutamate Receptor 3 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metabotropic Glutamate Receptor 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Metabotropic Glutamate Receptor 3 market include Eli Lilly and Company, Prexton Therapeutics SA, Domain Therapeutics SA, Denovo Biopharma LLC, Aevi Genomic Medicine Inc and Addex Therapeutics Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Metabotropic Glutamate Receptor 3 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Metabotropic Glutamate Receptor 3 market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Metabotropic Glutamate Receptor 3 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Metabotropic Glutamate Receptor 3.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Metabotropic Glutamate Receptor 3 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Metabotropic Glutamate Receptor 3 Market by Company

Eli Lilly and Company

Prexton Therapeutics SA

Domain Therapeutics SA

Denovo Biopharma LLC

Aevi Genomic Medicine Inc

Addex Therapeutics Ltd

Metabotropic Glutamate Receptor 3 Segment by Type

DT-010991

LY-3020371

VU-0092273

Others

Metabotropic Glutamate Receptor 3 Segment by Application

Autism

Chronic Pain

Glioma

Others

Metabotropic Glutamate Receptor 3 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metabotropic Glutamate Receptor 3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metabotropic Glutamate Receptor 3 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metabotropic Glutamate Receptor 3.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Metabotropic Glutamate Receptor 3 companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Metabotropic Glutamate Receptor 3 Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Metabotropic Glutamate Receptor 3 Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Metabotropic Glutamate Receptor 3 Market Share by Region (2021-2026) Table 4. Global Metabotropic Glutamate Receptor 3 Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Metabotropic Glutamate Receptor 3 Market Share by Region (2027-2032) Table 6. Global Metabotropic Glutamate Receptor 3 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Metabotropic Glutamate Receptor 3 Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Metabotropic Glutamate Receptor 3 Market Size Share by Type (2021-2026) Table 9. Global Metabotropic Glutamate Receptor 3 Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Metabotropic Glutamate Receptor 3 Market Size Share Forecasted by Type (2027-2032) Table 11. North America Metabotropic Glutamate Receptor 3 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Metabotropic Glutamate Receptor 3 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Metabotropic Glutamate Receptor 3 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Metabotropic Glutamate Receptor 3 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Metabotropic Glutamate Receptor 3 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Metabotropic Glutamate Receptor 3 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Metabotropic Glutamate Receptor 3 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Metabotropic Glutamate Receptor 3 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Metabotropic Glutamate Receptor 3 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Metabotropic Glutamate Receptor 3 Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Metabotropic Glutamate Receptor 3 Market Size Share by Application (2021-2026) Table 24. Global Metabotropic Glutamate Receptor 3 Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Metabotropic Glutamate Receptor 3 Market Size Share Forecasted by Application (2027-2032) Table 26. North America Metabotropic Glutamate Receptor 3 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Metabotropic Glutamate Receptor 3 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Metabotropic Glutamate Receptor 3 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Metabotropic Glutamate Receptor 3 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Metabotropic Glutamate Receptor 3 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Metabotropic Glutamate Receptor 3 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Metabotropic Glutamate Receptor 3 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Metabotropic Glutamate Receptor 3 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Metabotropic Glutamate Receptor 3 Industry Trends Table 37. Metabotropic Glutamate Receptor 3 Industry Drivers Table 38. Metabotropic Glutamate Receptor 3 Industry Opportunities and Challenges Table 39. Metabotropic Glutamate Receptor 3 Industry Restraints Table 40. Global Metabotropic Glutamate Receptor 3 Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Company (2021-2026) Table 42. Global Metabotropic Glutamate Receptor 3 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Metabotropic Glutamate Receptor 3 Key Company Headquarters & Area Served Table 44. Global Metabotropic Glutamate Receptor 3 Company, Product Type & Application Table 45. Global Metabotropic Glutamate Receptor 3 Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Metabotropic Glutamate Receptor 3 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Eli Lilly and Company Company Information Table 49. Eli Lilly and Company Business Overview Table 50. Eli Lilly and Company Metabotropic Glutamate Receptor 3 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Eli Lilly and Company Metabotropic Glutamate Receptor 3 Product Portfolio Table 52. Eli Lilly and Company Recent Development Table 53. Prexton Therapeutics SA Company Information Table 54. Prexton Therapeutics SA Business Overview Table 55. Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Product Portfolio Table 57. Prexton Therapeutics SA Recent Development Table 58. Domain Therapeutics SA Company Information Table 59. Domain Therapeutics SA Business Overview Table 60. Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Product Portfolio Table 62. Domain Therapeutics SA Recent Development Table 63. Denovo Biopharma LLC Company Information Table 64. Denovo Biopharma LLC Business Overview Table 65. Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Product Portfolio Table 67. Denovo Biopharma LLC Recent Development Table 68. Aevi Genomic Medicine Inc Company Information Table 69. Aevi Genomic Medicine Inc Business Overview Table 70. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Product Portfolio Table 72. Aevi Genomic Medicine Inc Recent Development Table 73. Addex Therapeutics Ltd Company Information Table 74. Addex Therapeutics Ltd Business Overview Table 75. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Product Portfolio Table 77. Addex Therapeutics Ltd Recent Development Table 78. North America Metabotropic Glutamate Receptor 3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 79. North America Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026) & (US$ Million) Table 80. North America Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2026) Table 81. North America Metabotropic Glutamate Receptor 3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 82. North America Metabotropic Glutamate Receptor 3 Market Share Forecast by Country (2027-2032) Table 83. Europe Metabotropic Glutamate Receptor 3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 84. Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026) & (US$ Million) Table 85. Europe Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2026) Table 86. Europe Metabotropic Glutamate Receptor 3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 87. Europe Metabotropic Glutamate Receptor 3 Market Share Forecast by Country (2027-2032) Table 88. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026) & (US$ Million) Table 90. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2026) Table 91. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Share Forecast by Country (2027-2032) Table 93. Latin America Metabotropic Glutamate Receptor 3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Latin America Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026) & (US$ Million) Table 95. Latin America Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2026) Table 96. Latin America Metabotropic Glutamate Receptor 3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Latin America Metabotropic Glutamate Receptor 3 Market Share Forecast by Country (2027-2032) Table 98. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026) & (US$ Million) Table 100. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2026) Table 101. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Share Forecast by Country (2027-2032) Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Metabotropic Glutamate Receptor 3 Product Image Figure 3. Global Metabotropic Glutamate Receptor 3 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 5. Global Metabotropic Glutamate Receptor 3 Market Share by Region: 2025 VS 2032 Figure 6. Global Metabotropic Glutamate Receptor 3 Market Share by Region (2021-2032) Figure 7. North America Metabotropic Glutamate Receptor 3 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Metabotropic Glutamate Receptor 3 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Metabotropic Glutamate Receptor 3 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. DT-010991 Image Figure 13. Global DT-010991 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. LY-3020371 Image Figure 15. Global LY-3020371 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. VU-0092273 Image Figure 17. Global VU-0092273 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Metabotropic Glutamate Receptor 3 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Metabotropic Glutamate Receptor 3 Market Share by Type 2025 VS 2032 Figure 22. North America Metabotropic Glutamate Receptor 3 Market Size Share by Type (2021-2032) Figure 23. Europe Metabotropic Glutamate Receptor 3 Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size Share by Type (2021-2032) Figure 25. Latin America Metabotropic Glutamate Receptor 3 Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Metabotropic Glutamate Receptor 3 Market Size Share by Type (2021-2032) Figure 27. Autism Image Figure 28. Global Autism Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Chronic Pain Image Figure 30. Global Chronic Pain Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Glioma Image Figure 32. Global Glioma Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Metabotropic Glutamate Receptor 3 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Metabotropic Glutamate Receptor 3 Market Share by Application 2025 VS 2032 Figure 37. North America Metabotropic Glutamate Receptor 3 Market Size Share by Application (2021-2032) Figure 38. Europe Metabotropic Glutamate Receptor 3 Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size Share by Application (2021-2032) Figure 40. Latin America Metabotropic Glutamate Receptor 3 Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Metabotropic Glutamate Receptor 3 Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Metabotropic Glutamate Receptor 3 Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Metabotropic Glutamate Receptor 3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Metabotropic Glutamate Receptor 3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2032) Figure 47. Europe Metabotropic Glutamate Receptor 3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Metabotropic Glutamate Receptor 3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2032) Figure 50. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2032) Figure 53. Latin America Metabotropic Glutamate Receptor 3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Metabotropic Glutamate Receptor 3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2032) Figure 56. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • DT-010991
  • LY-3020371
  • VU-0092273
  • Others
Applications
  • Autism
  • Chronic Pain
  • Glioma
  • Others
Companies covered
  • Eli Lilly and Company
  • Prexton Therapeutics SA
  • Domain Therapeutics SA
  • Denovo Biopharma LLC
  • Aevi Genomic Medicine Inc
  • Addex Therapeutics Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Metabotropic Glutamate Receptor 3 Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Metabotropic Glutamate Receptor 3 Market Size by Region (2021-2032)
  5. 1.4.1 Global Metabotropic Glutamate Receptor 3 Market Size by Region (2021-2026)
  6. 1.4.2 Global Metabotropic Glutamate Receptor 3 Market Size by Region (2027-2032)
  7. 1.5 Key Regions Metabotropic Glutamate Receptor 3 Market Size (2021-2032)
  8. 1.5.1 North America Metabotropic Glutamate Receptor 3 Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Metabotropic Glutamate Receptor 3 Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Metabotropic Glutamate Receptor 3 Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Growth Rate (2021-2032)
2 Metabotropic Glutamate Receptor 3 Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 DT-010991
  3. 2.1.2 LY-3020371
  4. 2.1.3 VU-0092273
  5. 2.1.4 Others
  6. 2.2 Global Metabotropic Glutamate Receptor 3 Market Size by Type
  7. 2.2.1 Global Metabotropic Glutamate Receptor 3 Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Metabotropic Glutamate Receptor 3 Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Metabotropic Glutamate Receptor 3 Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Metabotropic Glutamate Receptor 3 Market Size by Regions
  11. 2.3.1 North America Metabotropic Glutamate Receptor 3 Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Metabotropic Glutamate Receptor 3 Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Metabotropic Glutamate Receptor 3 Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Metabotropic Glutamate Receptor 3 Market Size Breakdown by Type (2021-2026)
3 Metabotropic Glutamate Receptor 3 Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Autism
  3. 3.1.2 Chronic Pain
  4. 3.1.3 Glioma
  5. 3.1.4 Others
  6. 3.2 Global Metabotropic Glutamate Receptor 3 Market Size by Application
  7. 3.2.1 Global Metabotropic Glutamate Receptor 3 Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Metabotropic Glutamate Receptor 3 Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Metabotropic Glutamate Receptor 3 Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Metabotropic Glutamate Receptor 3 Market Size by Regions
  11. 3.3.1 North America Metabotropic Glutamate Receptor 3 Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Metabotropic Glutamate Receptor 3 Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Metabotropic Glutamate Receptor 3 Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Metabotropic Glutamate Receptor 3 Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Metabotropic Glutamate Receptor 3 Industry Trends
  2. 4.2 Metabotropic Glutamate Receptor 3 Industry Drivers
  3. 4.3 Metabotropic Glutamate Receptor 3 Industry Opportunities and Challenges
  4. 4.4 Metabotropic Glutamate Receptor 3 Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Metabotropic Glutamate Receptor 3 Revenue (2021-2026)
  2. 5.2 Global Metabotropic Glutamate Receptor 3 Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Metabotropic Glutamate Receptor 3 Key Company Headquarters & Area Served
  4. 5.4 Global Metabotropic Glutamate Receptor 3 Company, Product Type & Application
  5. 5.5 Global Metabotropic Glutamate Receptor 3 Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Metabotropic Glutamate Receptor 3 Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Metabotropic Glutamate Receptor 3 Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Metabotropic Glutamate Receptor 3 Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Eli Lilly and Company
  2. 6.1.1 Eli Lilly and Company Company Information
  3. 6.1.2 Eli Lilly and Company Business Overview
  4. 6.1.3 Eli Lilly and Company Metabotropic Glutamate Receptor 3 Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Eli Lilly and Company Metabotropic Glutamate Receptor 3 Product Portfolio
  6. 6.1.5 Eli Lilly and Company Recent Developments
  7. 6.2 Prexton Therapeutics SA
  8. 6.2.1 Prexton Therapeutics SA Company Information
  9. 6.2.2 Prexton Therapeutics SA Business Overview
  10. 6.2.3 Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Product Portfolio
  12. 6.2.5 Prexton Therapeutics SA Recent Developments
  13. 6.3 Domain Therapeutics SA
  14. 6.3.1 Domain Therapeutics SA Company Information
  15. 6.3.2 Domain Therapeutics SA Business Overview
  16. 6.3.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Product Portfolio
  18. 6.3.5 Domain Therapeutics SA Recent Developments
  19. 6.4 Denovo Biopharma LLC
  20. 6.4.1 Denovo Biopharma LLC Company Information
  21. 6.4.2 Denovo Biopharma LLC Business Overview
  22. 6.4.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Product Portfolio
  24. 6.4.5 Denovo Biopharma LLC Recent Developments
  25. 6.5 Aevi Genomic Medicine Inc
  26. 6.5.1 Aevi Genomic Medicine Inc Company Information
  27. 6.5.2 Aevi Genomic Medicine Inc Business Overview
  28. 6.5.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Product Portfolio
  30. 6.5.5 Aevi Genomic Medicine Inc Recent Developments
  31. 6.6 Addex Therapeutics Ltd
  32. 6.6.1 Addex Therapeutics Ltd Company Information
  33. 6.6.2 Addex Therapeutics Ltd Business Overview
  34. 6.6.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Product Portfolio
  36. 6.6.5 Addex Therapeutics Ltd Recent Developments
7 North America
  1. 7.1 North America Metabotropic Glutamate Receptor 3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026)
  3. 7.3 North America Metabotropic Glutamate Receptor 3 Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Metabotropic Glutamate Receptor 3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026)
  3. 8.3 Europe Metabotropic Glutamate Receptor 3 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Metabotropic Glutamate Receptor 3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026)
  3. 10.3 South America Metabotropic Glutamate Receptor 3 Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst